Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,228 | 49,591 | 52,570 | 0 | 0 |
| TOTAL | $47,669 | $49,914 | $52,618 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 182 | 200 | 55 | N/A | N/A |
| TOTAL | $182 | $200 | $55 | $N/A | $N/A |
| Total Assets | $47,851 | $50,114 | $52,673 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 89 | 193 | 550 | 0 | 0 |
| Accrued Expenses | 363 | 447 | 1,925 | 0 | 0 |
| TOTAL | $452 | $640 | $2,475 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $452 | $640 | $2,475 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,310 | 10,307 | 10,237 | N/A | N/A |
| Retained earnings | -11,220 | -9,070 | -7,677 | 0 | 0 |
| TOTAL | $47,399 | $49,474 | $50,198 | $0 | $0 |
| Total Liabilities And Equity | $47,851 | $50,114 | $52,673 | $0 | $0 |